Prescription opioid misusers exhibit blunted parasympathetic regulation during inhibitory control challenge

Psychopharmacology (Berl). 2021 Mar;238(3):765-774. doi: 10.1007/s00213-020-05729-z. Epub 2021 Jan 7.

Abstract

Rationale: Among opioid-treated chronic pain patients, response inhibition deficits in emotional contexts may contribute to opioid misuse.

Objectives: Using high-frequency heart rate variability (HF-HRV) to index-impaired response inhibition, we examined associations between opioid misuse and response inhibition in emotional and neutral contexts in a sample of opioid-treated chronic pain patients.

Method: Chronic pain patients taking opioid analgesics (N = 97) for ≥ 90 days completed an Emotional Go/NoGo task that presented an inhibitory control challenge in the context of neutral, opioid, negative affective, and positive affective background images while HF-HRV was computed. Opioid misuse and craving were assessed. Using a validated cut-point on the Current Opioid Misuse Measure, participants were classified as opioid misusers or non-misusers. Opioid misuse was examined as a predictor of behavioral and HF-HRV metrics of response inhibition.

Results: Negative affective and opioid images elicited more errors of commission (p = .002, η2partial = .16) and slowed reaction times (p = .045, η2partial = .09) compared to neutral and positive affective images, respectively. Though no between-group behavioral differences were observed on the task, opioid misusers exhibited significantly blunted phasic HF-HRV during the task relative to non-misusers (p = .027, η2partial = .11). HF-HRV during the task was significantly inversely associated with opioid craving. It was not clear whether these autonomic findings reflected a durable phenotypic difference between groups or between-group differences in opioid dosing and withdrawal.

Conclusion: Reduced parasympathetic regulation during inhibitory control challenge may indicate heightened opioid misuse risk among opioid-treated chronic pain patients.

Keywords: Chronic pain; Cognition; Heart rate variability; Inhibitory control; Opioid misuse.

MeSH terms

  • Adult
  • Analgesics, Opioid / adverse effects*
  • Analgesics, Opioid / therapeutic use
  • Autonomic Nervous System / drug effects*
  • Chronic Pain / drug therapy
  • Craving / drug effects*
  • Emotions / drug effects*
  • Female
  • Heart Rate / drug effects*
  • Humans
  • Male
  • Middle Aged
  • Opioid-Related Disorders / psychology*
  • Prescription Drugs

Substances

  • Analgesics, Opioid
  • Prescription Drugs